Autophagy inhibition enhances sensitivity of endometrial carcinoma cells to paclitaxel

International Journal of Oncology

Volumn 46, Issue 6, 2015, Pages 2399-2408

  Liu, Suiling ^a   Li, Xiaomao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Autophagy; Chloroquine; Endometrial carcinoma; Paclitaxel; ROS

Indexed keywords

ACETYLCYSTEINE; BECLIN 1; CHLOROQUINE; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; PACLITAXEL; PROTEIN P62; REACTIVE OXYGEN METABOLITE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; YELLOW FLUORESCENT PROTEIN; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; LIGHT CHAIN 3, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUBULIN MODULATOR;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CARCINOMA CELL; CELL DEATH; CELL MEMBRANE; CELL VIABILITY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DRUG POTENTIATION; DRUG SENSITIVITY; ENDOMETRIUM CARCINOMA; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IC50; IMMUNOBLOTTING; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; DRUG EFFECTS; ENDOMETRIUM TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; CHLOROQUINE; DRUG SYNERGISM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; PACLITAXEL; RNA-BINDING PROTEINS; TUBULIN MODULATORS;

EID: 84928529109     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2937     Document Type: Article

References (35)

1. Mazgani M, Le N and Hoskins PJ; British Columbia Cancer Agency: Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer - the British Columbia Cancer Agency experience. Gynecol Oncol 111: 474-477, 2008.
2. Pectasides D, Xiros N, Papaxoinis G, Pectasides E, Sykiotis C, Koumarianou A, Psyrri A, Gaglia A, Kassanos D, Gouveris P, et al: Carboplatin and paclitaxel in advanced or metastatic endometrial cancer. Gynecol Oncol 109: 250-254, 2008.
3. Sorbe B, Andersson H, Boman K, Rosenberg P and Kalling M: Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up. Int J Gynecol Cancer 18: 803-808, 2008.
4. Vandenput I, Vergote I, Leunen K, Berteloot P, Neven P and Amant F: Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma. Int J Gynecol Cancer 19: 1147-1151, 2009.
5. Lefranc F, Facchini V and Kiss R: Proautophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12: 1395-1403, 2007.
6. Mathew R, Karantza-Wadsworth V and White E: Role of autophagy in cancer. Nat Rev Cancer 7: 961-967, 2007.
7. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta 1793: 1524-1532, 2009.
8. Zhang Q, Si S, Schoen S, Chen J, Jin XB and Wu G: Suppression of autophagy enhances preferential toxicity of paclitaxel to folliculin-deficient renal cancer cells. J Exp Clin Cancer Res 32: 99, 2013.
9. Kim HJ, Lee SG, Kim YJ, Park JE, Lee KY, Yoo YH and Kim JM: Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells. Int J Oncol 42: 1985-1992, 2013.
10. Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y and Yuan H: Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 307: 141-148, 2011.
11. Ajabnoor GM, Crook T and Coley HM: Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells. Cell Death Dis 3: e260, 2012.
12. Eum KH and Lee M: Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-rastransformed fibroblasts. Mol Cell Biochem 348: 61-68, 2011.
13. Veldhoen RA, Banman SL, Hemmerling DR, Odsen R, Simmen T, Simmonds AJ, Underhill DA and Goping IS: The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis. Oncogene 32: 736-746, 2013.
14. Mizushima N and Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 3: 542-545, 2007.
15. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, et al: Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544, 2012.
16. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G and Johansen T: p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145, 2007.
17. Ichimura Y and Komatsu M: Selective degradation of p62 by autophagy. Semin Immunopathol 32: 431-436, 2010.
18. Luiken JJ, Aerts JM and Meijer AJ: The role of the intralysosomal pH in the control of autophagic proteolytic flux in rat hepatocytes. Eur J Biochem 235: 564-573, 1996.
19. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A and Thompson CB: Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117: 326-336, 2007.
20. Maclean KH, Dorsey FC, Cleveland JL and Kastan MB: Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 118: 79-88, 2008.
21. Alexandre J, Batteux F, Nicco C, Chéreau C, Laurent A, Guillevin L, Weill B and Goldwasser F: Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer 119: 41-48, 2006.
22. Ramanathan B, Jan KY, Chen CH, Hour TC, Yu HJ and Pu YS: Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 65: 8455-8460, 2005.
23. Lyle PA, Mitsopoulos P and Suntres ZE: N-acetyl cysteine modulates the cytotoxic effects of Paclitaxel. Chemotherapy 57: 298-304, 2011.
24. Dewaele M, Maes H and Agostinis P: ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy. Autophagy 6: 838-854, 2010.
25. Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K and Tsubura A: Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 40: 1020-1028, 2012.
26. Kim JY, Cho TJ, Woo BH, Choi KU, Lee CH, Ryu MH and Park HR: Curcumin-induced autophagy contributes to the decreased survival of oral cancer cells. Arch Oral Biol 57: 1018-1025, 2012.
27. Yang L, Yang M, Zhang H, Wang Z, Yu Y, Xie M, Zhao M, Liu L and Cao L: S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid leukemia cell death by down-regulating autophagy. Int J Mol Med 29: 65-72, 2012.
28. Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF and Shih CM: Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Free Radic Biol Med 52: 377-391, 2012.
29. Cheng P, Ni Z, Dai X, Wang B, Ding W, Rae Smith A, Xu L, Wu D, He F and Lian J: The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma [corrected] cells. Cell Death Dis 4: e489, 2013.
30. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y and Kondo S: Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24: 980-991, 2005.
31. Chinnadurai G, Vijayalingam S and Gibson SB: BNIP3 subfamily BH3-only proteins: Mitochondrial stress sensors in normal and pathological functions. Oncogene 27 (Suppl 1): S114-S127, 2008.
32. Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M, Galavotti S, Young KW, Selmi T, Yacobi R, et al: Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 119: 1109-1123, 2009.
33. Ni Z, Wang B, Dai X, Ding W, Yang T, Li X, Lewin S, Xu L, Lian J and He F: HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway. Free Radic Biol Med 70: 194-203, 2014.
34. Sun K, Xie X, Liu Y, Han Z, Zhao X, Cai N, Zhang S, Song J and Wei L: Autophagy lessens ischemic liver injury by reducing oxidative damage. Cell Biosci 3: 26, 2013.
35. Guo XL, Li D, Hu F, Song JR, Zhang SS, Deng WJ, Sun K, Zhao QD, Xie XQ, Song YJ, et al : Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 320: 171-179, 2012.